Norovirus and sapovirus antigens

Details for Australian Patent Application No. 2006335256 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors Medina-Selby, Angelica; McCoin, Colin; Vajdy, Michael; Coit, Doris; Houghton, Michael

Agent FB Rice

Pub. Number AU-B-2006335256

PCT Pub. Number WO2007/081447

Priority 60/739,217 22.11.05 US

Filing date 22 November 2006

Wipo publication date 19 July 2007

Acceptance publication date 18 October 2012

International Classifications

C12N 15/00 Mutation or genetic engineering

A61K 39/12 Medicinal preparations containing antigens or antibodies - Viral antigens

C07K 14/08 Peptides having more than 20 amino acids

C07K 16/10 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/081447 Priority application(s): WO2007/081447

18 October 2012 Application Accepted

  Published as AU-B-2006335256

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006335259-Device for managing termination of conductors with jack modules

2006335254-Split-cycle air hybrid engine